PSMA PET/CT is currently the best available imaging technique to differentiate local relapse in the prostate bed, pelvic lymph node metastases or even metastatic disease in patients with biochemical persistence or recurrence [31]. The gene discussed is FOLH1; the disease is metastatic neoplasm.